MeSH tree: C04.588.448
The U.S. Food and Drug Administration has approved Takeda Pharmaceuticals' Mimrylo (rusfertide) as a new treatment for adults with polycythemia vera who have not achieved adequate control with existing therapies.
Sep 4, 2026
0
9
Over the past 75 years, advances in the treatment of major blood cancers have saved more than 25 million years of life in the United States, according to results of an analysis led by researchers at Blood Cancer United and ...
Sep 1, 2026
0
3
Precancerous blood cells can actively reshape their surroundings, prematurely aging cells in the bone marrow to create conditions that favor their own growth and potentially increase the risk of blood cancer, according to ...
Aug 27, 2026
0
8
Researchers from the German Cancer Research Center (DKFZ), the HI-STEM* Stem Cell Institute and Heidelberg University Hospital (UKHD) have developed "HemaGuide," an AI assistant that supports physicians in making difficult ...
Jul 6, 2026
0
7
Patients with multiple myeloma (MM) have a distinct pattern of second primary malignancy (SPM), with a markedly increased risk of hematologic SPMs, according to a review published online April 6 in Frontiers in Oncology.
Apr 30, 2026
0
6
As the body ages, cells naturally accumulate dozens of genetic mutations each year. New research from Boston Children's Hospital, published in Cell, finds that the brain's resident immune cells, microglia, amass mutations ...
Apr 21, 2026
0
96
Scientists at St. Jude Children's Research Hospital, the American Society for Hematology (ASH) and the Munich Leukemia Laboratory have developed a data-sharing platform that unites genomics, gene expression and clinical information ...
Apr 6, 2026
0
4
When patients start getting treated for conditions like psoriatic arthritis, or connective tissue diseases like lupus and systemic sclerosis, their heightened risk of cancer gradually decreases, according to a new five-year ...
Mar 31, 2026
0
8
Seventy-five percent of patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN) who were treated with the antibody-drug conjugate (ADC) pivekimab sunirine (PVEK) had a complete response, according to new data from ...
Feb 12, 2026
0
7
Cancer researchers working on immunotherapies have made a big discovery: SLAMF6, a molecule on the surface of immune cells that prevents T cells from effectively attacking tumors—and, in mice, they've found a way to neutralize ...
Feb 12, 2026
0
33
